Clinical Trial Update: RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update describes RV630, an investigational approach to control HIV through immune enhancement and vaccination, which is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• RV630

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: HIV Infections, PLWH | Phase 1 | Status: RECRUITING